# New Biomarkers in Pancreatic Cancer Using EXPEL Concept

> **NCT03791073** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 200 (estimated)

## Conditions studied

- Oncology

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03791073
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-01
- **Primary completion:** 2019-01-01
- **Final completion:** 2024-11-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03791073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03791073, "New Biomarkers in Pancreatic Cancer Using EXPEL Concept". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT03791073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*